Anthraquinone intercalators as carrier molecules for second-generation platinum anticancer drugs

Author： Gibson D.   Binyamin I.   Haj M.   Ringel I.   Ramu A.   Katzhendler J.  

Publisher： Elsevier

ISSN： 0223-5234

Source： European Journal of Medicinal Chemistry, Vol.32, Iss.10, 1997-10, pp. : 823-831

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of Second-Generation Antiepileptic Drugs in the Pediatric Population

By Chung Allison M.   Eiland Lea S.  

Pediatric Drugs, Vol. 10, Iss. 4, 2008-01 ,pp. : 217-254

Adis International

Access to resources Recommend Favorite

Evaluation of Interactions Between Platinum-/Ruthenium-Based Anticancer Agents and Human Serum Albumin: Development of HSA Carrier for Metal-Based Drugs

By  

Current Pharmaceutical Design, Vol. 21, Iss. 14, 2015-04 ,pp. : 1848-1861

Bentham Science Publishers

Access to resources Recommend Favorite

Membrane Transporters as Determinants of the Pharmacology of Platinum Anticancer Drugs

By  

Current Cancer Drug Targets, Vol. 12, Iss. 8, 2012-10 ,pp. : 962-986

Bentham Science Publishers

Access to resources Recommend Favorite

Second-generation kinase inhibitors

By Klebl Bert M   Müller Gerhard  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 5, 2005-10 ,pp. : 975-993

Informa Healthcare

Access to resources Recommend Favorite

Cardiotoxicity of Second-Generation Antihistamines

By Roberts D.J.  

Drugs, Vol. 57, Iss. 6, 1999-06 ,pp. : 1033-1034

Adis International

Access to resources Recommend Favorite